Global Lipase Testing Market Report and Forecast 2024-2032

Global Lipase Testing Market Outlook

The global lipase testing market is being aided by the rising lipase market, which is expected to grow at a CAGR of 5% in the forecast period of 2024-2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to Significantly Contribute to the Growth of the Lipase Testing Industry

North America is one of the leading regions in the industry and is expected to significantly contribute to the industry growth over the forecast period. The factors driving the growth of the industry in North America include the availability of advanced diagnostic facilities and the presence of developed healthcare infrastructure in the region. Meanwhile, the Asia Pacific is expected to witness a robust growth in the coming years. This can be attributed to the presence of a large patient pool, growing R&D activities, and the increasing government investments to develop the healthcare facilities in the region. Other regions, namely, Latin America and the Middle East and Africa are expected to provide lucrative growth opportunities for the market expansion in the forecast period.

Lipase Testing: Market Segmentation

Lipase is an enzyme secreted by pancreas into the digestive tract. It breaks down fats into fatty acids and glycerol and helps in their digestion. For digestive system to function normally, the concentration of lipase should be 10–73 units per litre (U/L) for individuals over 16 years of age. Abnormally high levels of lipase in the blood indicate health conditions like pancreatic cancer, acute pancreatitis, chronic pancreatitis, and celiac disease, among others. Lipase testing is predominantly used for the initial diagnosis of pancreatic function; however, it can also be performed to monitor other health conditions.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on type, the market is divided into:

• Hepatic Lipase
• Total Lipase
• Pancreatic Lipase
• Others

By technology, the industry can be segmented into:

• Spectrophotometric 
• ELISA
• Others

On the basis of end use, the industry is categorised into:

• Diagnostic Laboratories 
• Special Clinics
• Hospitals
• Research Centres
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Prevalence of Pancreatic Disorders and Increase in the Number of Diagnostic Facilities to Bolster the Growth of the Lipase Testing Industry

The rise in the number of diagnostic centres and the growing cases of pancreatic disorders are the major factors driving the growth of the lipase testing industry. The market is being supported by the rise in patient pool, changing dietary patterns, increasing sedentary lifestyles, growing incidences of pancreatic cancer, and developing healthcare facilities. As lipase testing also plays a crucial role in measuring lipase levels in biological samples, the growing research activities, and clinical trials across the globe are expected to further boost the industry growth over the forecast period.

Key Industry Players in the Global Lipase Testing Market

The report gives a detailed analysis of the following key players in the global lipase testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Creative Biomart Inc.   
• LifeSpan BioSciences, Inc
• Fitzgerald Industries International
• Athenese-Dx Private Limited
• BioAssay Systems
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report